Estie Mermelstein, MSN, FNP-BC

Estie Mermelstein, MSN, FNP-BC, earned her Master of Science in nursing from Columbia University School of Nursing. She has worked as a nurse in women’s health and as a nurse practitioner in family medicine. Estie also earned a Bachelor of Arts in journalism and was editor-in-chief of her undergraduate newspaper. She currently freelances in medical communications with a focus on clinician-facing content. She and her husband have three young children and live in New Jersey.

All articles by Estie Mermelstein, MSN, FNP-BC

HIV/AIDS

IL-21 Receptor Levels Associated With HIV-1 Viral Load and Disease Severity

Estie Mermelstein, MSN, FNP-BC

August 3, 2021

Researchers examined the expression of IL-21 receptor during HIV-1 infection and its role in HIV-1-specific CD8+ T cell maintenance and subsequent viral control.

HIV/AIDS

RSV and Parainfluenza Increase Hospitalization Risk in HIV-Exposed Infants

Estie Mermelstein, MSN, FNP-BC

July 30, 2021

As HIV-exposed, uninfected infants have higher rates of morbidity and mortality than HIV-unexposed uninfected infants, a study was conducted to analyze whether particular infections or immune responses contribute to hospitalization.

Hepatitis

Opioid Agonist Therapy Linked to Increased HCV Treatment Rates in People Who Inject Drugs

Estie Mermelstein, MSN, FNP-BC

July 13, 2021

Researchers studied the impact of current opioid agonist therapy on initiation of chronic hepatitis C virus treatment among a population of individuals who inject drugs.

Genitourinary

UTI Study Maps Escherichia coli Antimicrobial Resistance Trends in the United States

Estie Mermelstein, MSN, FNP-BC

July 12, 2021

Investigators evaluated resistance to fluoroquinolones, nitrofurantoin, and trimethoprim-sulfamethoxazole in patients with uncomplicated urinary tract infection.

HIV/AIDS

At the Intersection of 2 Pandemics: The Impact of COVID-19 on HIV

Estie Mermelstein, MSN, FNP-BC

July 9, 2021

A body of emerging research is attempting to quantify changes occurring as a result of the impact of COVID-19 on the HIV pandemic.

HIV/AIDS

Medication for Opioid Abuse Linked to Better HIV Viral Suppression, ART Adherence

Estie Mermelstein, MSN, FNP-BC

July 9, 2021

Researchers attempted to determine if medications for opioid use disorder integrated with infectious disease measures can lead to better infectious disease outcomes.